Hypofibrinogenemia Clinical Trial
Official title:
A Prospective, Multicenter, Open-label, Single-arm Study to Evaluate the Efficacy and Safety of Human Plasma-derived Fibrinogen Concentrate (FIB Grifols) in Subjects With Congenital Afibrinogenaemia and Severe Hypofibrinogenemia Requiring Either On-demand Treatment for Acute Bleeding or Surgical Prophylaxis
This is a phase 3, multi-center, prospective, open-label, single-arm, clinical trial to be carried out in subjects with congenital fibrinogen deficiency manifested as afibrinogenemia or severe hypofibrinogenemia. This clinical trial is planned to be performed at study sites in multiple countries. It is planned to include a maximum of 32 adult and pediatric subjects with congenital fibrinogen deficiency in order to provide at least 28 evaluable acute bleeding episodes and/or surgical procedures.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT00916656 -
Fibrinogen Concentrate (Human) - Efficacy and Safety Study
|
Phase 3 | |
| Completed |
NCT05780125 -
Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness
|
Phase 2 | |
| Recruiting |
NCT03884725 -
Fibrinogen Concentrate In Children Cardiac Surgery 2
|
Phase 4 | |
| Completed |
NCT02822599 -
Human Fibrinogen Concentrate in Pediatric Cardiac Surgery
|
Phase 4 | |
| Recruiting |
NCT05634005 -
Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence
|
N/A | |
| Recruiting |
NCT05711524 -
Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen to Expedite Product Availability in Perioperative Bleeding
|
Phase 4 |